CVE-2017-6794

Description

A vulnerability in the CLI command-parsing code of Cisco Meeting Server could allow an authenticated, local attacker to perform command injection and escalate their privileges to root. The attacker must first authenticate to the application with valid administrator credentials. The vulnerability is due to insufficient validation of user-supplied input at the CLI for certain commands. An attacker could exploit this vulnerability by authenticating to the affected application and submitting a crafted CLI command for execution at the Cisco Meeting Server CLI. An exploit could allow the attacker to perform command injection and escalate their privilege level to root. Vulnerable Products: This vulnerability exists in Cisco Meeting Server software versions prior to and including 2.0, 2.1, and 2.2. Cisco Bug IDs: CSCvf53830.

Category

6.7
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.21%
Vendor Advisory cisco.com
Affected: n/a Cisco Meeting Server
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2017-6794?
CVE-2017-6794 has been scored as a medium severity vulnerability.
How to fix CVE-2017-6794?
To fix CVE-2017-6794, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-6794 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-6794 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-6794?
CVE-2017-6794 affects n/a Cisco Meeting Server.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.